Bausch Health Companies (BHC) Common Equity (2009 - 2026)

Bausch Health Companies has disclosed Common Equity across 18 years of filings, most recently posting -$1.8 billion for Q2 2026.

• In Q2 2026, Common Equity fell 1304.76% year-over-year to -$1.8 billion; the TTM figure through Jun 2026 stood at -$1.8 billion (down 1304.76% YoY), while the FY2025 annual figure was -$554.0 million, up 56.68% from the prior year.
• Common Equity came in at -$1.8 billion for Q2 2026 at Bausch Health Companies, down from -$1.1 billion in the prior quarter.
• In the past five years, Common Equity ranged from a high of $433.0 million in Q3 2022 to a low of -$1.8 billion in Q2 2026.
• Average Common Equity over 5 years is -$282.4 million, with a median of -$200.5 million recorded in 2024.
• Year-over-year, Common Equity soared 864.71% in 2022 and sank 1459.76% in 2024.
• Over 5 years, Common Equity stood at $260.0 million in 2022, then slumped by 131.54% to -$82.0 million in 2023, then slumped by 1459.76% to -$1.3 billion in 2024, then soared by 56.68% to -$554.0 million in 2025, then sank by 219.68% to -$1.8 billion in 2026.
• Per Business Quant data, the three most recent Common Equity figures were -$1.8 billion in Q2 2026, -$1.1 billion in Q1 2026, and -$554.0 million in Q4 2025.